Celgene and Covidien Lead Legg Mason's $332M Healthcare Stock Portfolio Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Pfizer Inc. (NYSE:PFE): On 06/30/2011, Legg Mason Investment ... |
